Novartis Gleevec Will Cost Patients As Much As $30,000 Per Year

Gleevec will cost between $2,000-$2,500 for a month of therapy, or up to $30,000 annually to treat chronic myeloid leukemia. The price is comparable to other chemotherapy and interferon therapies used in CML, Novartis Oncology President David Epstein maintained during a May 10 press conference.